{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:40:04Z","timestamp":1756478404226,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017515","name":"Heidelberg Foundation for Surgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gassur.2025.102051","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T02:00:42Z","timestamp":1743818442000},"page":"102051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of placental growth factor as a biomarker in patients with resectable gastric cancer"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-1654","authenticated-orcid":false,"given":"Ingmar F.","family":"Rompen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nerz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerma","family":"Crnovrsanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Musa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg Martin","family":"Haag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timon","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Longerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Al-Saeedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Sisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Nienh\u00fcser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.gassur.2025.102051_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/ijms21030951","article-title":"Oligometastatic gastroesophageal adenocarcinoma: molecular pathophysiology and current therapeutic approach","volume":"21","author":"Jung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gassur.2025.102051_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jss.2020.05.045","article-title":"Expression of angiogenic proteins in tumor and stroma affects survival in patients with gastric cancer","volume":"255","author":"Nienh\u00fcser","year":"2020","journal-title":"J Surg Res"},{"issue":"5","key":"10.1016\/j.gassur.2025.102051_bib4","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gassur.2025.102051_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","article-title":"Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis","volume":"219","author":"Spolverato","year":"2014","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.gassur.2025.102051_bib7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ejso.2022.11.093","article-title":"Recurrence patterns after curative gastrectomy for pStage II\/III gastric cancer: exploratory analysis of the randomized controlled JCOG1001 trial","volume":"49","author":"Toriumi","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2025.102051_bib8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.gassur.2025.102051_bib9","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1097\/JS9.0000000000000713","article-title":"Age-dependent benefit of neoadjuvant treatment in adenocarcinoma of the esophagus and gastroesophageal junction: a multicenter retrospective observational study of young versus old patients","volume":"109","author":"Rompen","year":"2023","journal-title":"Int J Surg"},{"issue":"12","key":"10.1016\/j.gassur.2025.102051_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2009.123","article-title":"Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas","volume":"22","author":"Langer","year":"2009","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00432-022-04408-0","article-title":"Predictive biomarkers in gastric cancer","volume":"149","author":"R\u00f6cken","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/ijms19010043","article-title":"Angiogenesis and anti-angiogenic therapy in gastric cancer","volume":"19","author":"Nienh\u00fcser","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.gassur.2025.102051_bib13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.gassur.2025.102051_bib14","article-title":"Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"issue":"9911","key":"10.1016\/j.gassur.2025.102051_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gassur.2025.102051_bib16","doi-asserted-by":"crossref","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"10.1016\/j.gassur.2025.102051_bib17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1541-7786.MCR-19-0077","article-title":"RETRACTED: KRAS activation in gastric adenocarcinoma stimulates epithelial-to-mesenchymal transition to cancer stem\u2013like cells and promotes metastasis","volume":"17","author":"Yoon","year":"2019","journal-title":"Mol Cancer Res"},{"issue":"5","key":"10.1016\/j.gassur.2025.102051_bib18","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.91.5.1858","article-title":"E-cadherin gene mutations in human gastric carcinoma cell lines","volume":"91","author":"Oda","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.gassur.2025.102051_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ccr.2011.05.007","article-title":"Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia","volume":"19","author":"Schmidt","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.gassur.2025.102051_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jcb.25762","article-title":"PlGF knockdown decreases tumorigenicity and stemness properties of spheroid body cells derived from gastric cancer cells","volume":"118","author":"Mahmoodi","year":"2017","journal-title":"J Cell Biochem"},{"issue":"3","key":"10.1016\/j.gassur.2025.102051_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cbf.3176","article-title":"PlGF knockdown inhibited tumor survival and migration in gastric cancer cell via PI3K\/Akt and p38MAPK pathways","volume":"34","author":"Akrami","year":"2016","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00423-023-02822-7","article-title":"Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective","volume":"408","author":"Sisic","year":"2023","journal-title":"Langenbecks Arch Surg"},{"issue":"10","key":"10.1016\/j.gassur.2025.102051_bib23","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1245\/s10434-024-15721-y","article-title":"Prognostic relevance of the proximal resection margin distance in distal gastrectomy for gastric adenocarcinoma","volume":"31","author":"Rompen","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2025.102051_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.gassur.2025.102051_bib25","first-page":"3149","article-title":"A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition","volume":"5","author":"Zhou","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib26","first-page":"241","article-title":"Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-\u03baB","volume":"38","author":"Levati","year":"2011","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.gassur.2025.102051_bib27","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3390\/ijms20122970","article-title":"Multifaceted role of the placental growth factor (PlGF) in the antitumor immune response and cancer progression","volume":"20","author":"Albonici","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"20","key":"10.1016\/j.gassur.2025.102051_bib28","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","volume":"88","author":"Maglione","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.gassur.2025.102051_bib29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00432-010-0816-9","article-title":"Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+\/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer","volume":"136","author":"Shen","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2025.102051_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41591-023-02758-x","article-title":"Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial","volume":"30","author":"Verschoor","year":"2024","journal-title":"Nat Med"},{"issue":"10294","key":"10.1016\/j.gassur.2025.102051_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib32","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1038\/s41467-022-33991-6","article-title":"PD-L1-directed PlGF\/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.gassur.2025.102051_bib33","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.7150\/jca.82876","article-title":"Clinical characteristics and oncological outcomes of surgically treated early-onset gastric adenocarcinoma \u2013 a retrospective cohort study","volume":"14","author":"Rompen","year":"2023","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2025.102051_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47429-5","article-title":"Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer","volume":"9","author":"Sch\u00f6lch","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.gassur.2025.102051_bib35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.2011.609","article-title":"A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours","volume":"106","author":"Lassen","year":"2012","journal-title":"Br J Cancer"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X25001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:26:15Z","timestamp":1756477575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X25001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1091255X25001106"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102051","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of placental growth factor as a biomarker in patients with resectable gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2025.102051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society for Surgery of the Alimentary Tract.","name":"copyright","label":"Copyright"}],"article-number":"102051"}}